Autoimmune and inflammatory responses in Kashin-Beck disease compared with rheumatoid arthritis and osteoarthritis

Human Immunology

Volumn 72, Issue 10, 2011, Pages 812-816

  Tian, Lifang ^a   Wang, Wei ^a   Hou, Weikun ^a   Tian, Juan ^a   Zhong, Nannan ^a   Sun, Jian ^a   Guo, Dawei ^b   Yao, Jianfeng ^c   Xu, Peng ^c   Su, Peihe ^d   He, Lan ^d   Lu, Shemin ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b Shaanxi Provincial Institute for Endemic Disease Control   (China)

^c Xi'an Red Cross Hospital   (China)

^d THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Autoimmunity; Cartilage; Collagen; Inflammation; Kashin Beck disease

Indexed keywords

AUTOANTIBODY; COLLAGEN ANTIBODY; COLLAGEN TYPE 11; COLLAGEN TYPE 2; COLLAGEN TYPE 9; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYTOKINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; NITRIC OXIDE; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; BIOASSAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; KASHIN BECK DISEASE; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; CASE-CONTROL STUDIES; COLLAGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLAMMATION; KASHIN-BECK DISEASE; MALE; MIDDLE AGED; NITRIC OXIDE; OSTEOARTHRITIS; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052970482     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.05.021     Document Type: Article

References (21)

1. Suetens C., Moreno-Reyes R., Chasseur C., Mathieu F., Begaux F., Haubruge E., et al. Epidemiological support for a multifactorial aetiology of Kashin-Beck disease in Tibet. Int Orthop 2001, 25:180-187.
2. Yamamuro T. Kashin-Beck disease: a historical overview. Int Orthop 2001, 25:134-137.
3. Cao J., Li S., Shi Z., Yue Y., Sun J., Chen J., et al. Articular cartilage metabolism in patients with Kashin-Beck disease: an endemic osteoarthropathy in China. Osteoarthritis Cartilage 2008, 16:680-688.
4. Miller E.J. Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin. Biochemistry 1972, 11:4903-4909.
5. Lu S.M., Carlsen S., Hansson A.S., Holmdahl R. Immunization of rats with homologous type XI collagen leads to chronic and relapsing arthritis with different genetics and joint pathology than arthritis induced with homologous type II collagen. J Autoimmun 2002, 18:199-211.
6. Morgan K., Claque R.B., Collins I., Ayad S., Phinn S.D., Holt P.J. Incidence of antibodies to native and denatured cartilage collagens (types II, IX, and XI) and to type I collagen in rheumatoid arthritis. Ann Rheum Dis 1987, 46:902-907.
7. Cook A.D., Rowley M.J., Mackay I.R., Gough A., Emery P. Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression. Arthritis Rheum 1996, 39:1720-1727.
8. Carlsen S., Nandakumar K.S., Holmdahl R. Type IX collagen deficiency enhances the binding of cartilage-specific antibodies and arthritis severity. Arthritis Res Ther 2006, 8:R102.
9. Nishimura K., Sugiyama D., Kogata Y., Tsuji G., Nakazawa T., Kawano S., et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007, 146:797-808.
10. Zhao J.X., Liu X.Y., Wang Z.M., Li Z.G. Significance of anti-CCP antibodies in modification of 1987 ACR classification criteria in diagnosis of rheumatoid arthritis. Clin Rheumatol 2010, 29:33-38.
11. Lopez-Hoyos M., Ruiz de Alegria C., Blanco R., Crespo J., Peña M., Rodriguez-Valverde V., et al. Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. Rheumatology 2004, 43:655-657.
12. Satoh K, Kawakami A, Shirabe S, Tamai M, Sato A, Tsujihata M, et al. Anti-cyclic citrullinated peptide antibody (anti-CCP antibody) is present in the sera of patients with dementia of Alzheimer's type in Asian. Acta Neurol Scand121:338-41.
13. Orge E., Cefle A., Yazici A., Gürel-Polat N., Hulagu S. The positivity of rheumatoid factor and anti-cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection. Rheumatol Int 2010, 30:485-488.
14. Vossenaar E.R., Smeets T.J.M., Kraan M.C., Raats J.M., van Venrooij W.J., Tak P.P. The presence of citrullinated proteins is no specific for rheumatoid synovial tissue. Arthritis Rheum 2004, 50:3485-3494.
15. Du H., Masuko-Hongo K., Nakamura H., Xiang Y., Bao C.D., Wang X.D., et al. The prevalence of autoantibodies against cartilage intermediate layer protein, YKL-39, osteopontin, and cyclic citrullinated peptide in patients with early-stage knee osteoarthritis: evidence of a variety of autoimmune processes. Rheumatol Int 2005, 26:35-41.
16. Nielen M.M.J., van Schaardenburg D., Reesink H.W., van de Stadt R.J., van der Horst-Bruinsma I.E., de Koning M.H.M.T., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380-386.
17. Kroot E.J.J.A., de Jong B.A.W., van Leeuwen M.A., Swinkels H., van den Hoogen F.H.J., van't Hof M., et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000, 43:1831-1835.
18. Day S.M., Lockhart J.C., Ferrell W.R., McLean J.S. Divergent roles of nitrergic and prostanoid pathways in chronic joint inflammation. Ann Rheum Dis 2004, 63:1564-1570.
19. Amin A.R., Attur M., Patel R.N., Thakker G.D., Marshall P.J., Rediske J., et al. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest 1997, 99:1231-1237.
20. Feldmann M., Maini R.N. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?. Annu Review Immunol 2001, 19:163-196.
21. Jäälinoja J., Nissilä M., Kauppi M., Hakala M., Laiho K., Karttunen R., et al. Serum antibodies against intact human collagen IX are elevated at the onset of RA but are not related to the development of erosions. J Rheumatol 2008, 35:745-751.